Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Inari Medical, Inc.

Inari Medical to Participate in the Jefferies London Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Reports Third Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical to Announce Third Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical to Present at Upcoming Investor Conferences
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Announces Chief Financial Officer Retirement and Succession Plan
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Reports Second Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical to Announce Second Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Files Patent Infringement Lawsuit Against Imperative Care and Truvic Medical
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Reports First Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical to Announce First Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Reports Fourth Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Closes Acquisition of LimFlow
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical to Present at Upcoming Investor Conferences
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Reports Third Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical to Announce Third Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical to Present at Upcoming Investor Conferences
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Inari Medical Reports Second Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Tickers NARI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.